TLR9 and preeclampsia: Even so, alterations in the expression and activity of TLR9 have been demonstrated in placentas and circulation of pregnant individuals diagnosed with pregnancy complications such as preeclampsia (11, 69–71), and this TLR9 dysregulation may alter the impact of CpG ODN exposure on immune modulation during pregnancy.